Congratulations to Precision’s Mark Clein on moderating a well attended panel at at HLTH Boston 2021. Did you miss “Driving Diversity in Clinical Trials,” where life sciences leaders discussed what they are doing to ensure diversity is deeply ingrained into the planning and execution of all clinical trials, leaving bias in the past?
Check back – it will be available on demand soon!
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
